Evidence map›Paper›PMID 40542863›Full record

ArticleJournal of molecular histology2025

Assessing the anticancer potential of Bergenia ciliata conjugated silk fibroin nanoparticles through histopathological and biomarkers study.

Faiza, Shaukat Ali, Muhammad Summer, Faiza Sharif

Erratum issuedAbstract read
PubMed Publisher
In one paragraph

Article in Journal of molecular histology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

4 authors.

FaizaMedical Toxicology and Biochemistry Laboratory, Department of Zoology, Government College University, Lahore, 54000, Pakistan.
Shaukat AliMedical Toxicology and Biochemistry Laboratory, Department of Zoology, Government College University, Lahore, 54000, Pakistan. dr.shaukatali@gcu.edu.pk.
Muhammad SummerMedical Toxicology and Biochemistry Laboratory, Department of Zoology, Government College University, Lahore, 54000, Pakistan. muhammad.summer@gcu.edu.pk.
Faiza SharifInterdisciplinary Research Centre in Biomedical Materials, COMSATS University Islamabad, Defence Road Off Raiwind Road, Lahore, Pakistan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The present research has aimed to formulate fibroin nanoparticles (FNPs) and Bergenia ciliata-loaded fibroin nanoparticles (BCFNPs) to investigate their antitumor activity against breast cancer in mice. The prepared FNPs and BCFNPs characterized by Ultraviolet-visible spectroscopy, Fourier transform infrared spectroscopy (FTIR), Scanning electron microscopy (SEM), Dynamic light scattering (DLS), Zeta potential measurement, Fourier-transform infrared spectroscopy (FT-IR), and X-ray diffraction (XRD). UV-Vis spectroscopy revealed characteristic peak at 282 nm for FNPs and 285 nm for BCFNPs, indicating the successful development of fibroin nanoparticles (FNPs) and Bergenia ciliata-loaded fibroin nanoparticles (BCFNPs). FT-IR analysis identified characteristic absorption bands in the FNPs spectrum at 3350 cm

Indexed as

Antineoplastic AgentsBiomarkers, TumorFibroinsNanoparticlesAnimalsBreast NeoplasmsCell Line, TumorFemaleHumansMiceSpectroscopy, Fourier Transform InfraredX-Ray DiffractionAntineoplastic AgentsBiomarkers, TumorFibroinsBergenia ciliataBergenia ciliata loaded fibroin nanoparticlesBreast cancerDuctal carcinoma

Identifiers

PMID40542863

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.